Understanding virologic heterogeneity in chronic hepatitis B treatment

Understanding virologic heterogeneity in chronic hepatitis B treatment

Saved in:

Bibliographic Details
Main Authors:	Renqi Luo, Xue Ran, Ruihan Sun
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	JHEP Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589555924002532
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment”
by: Philippa C. Matthews, et al.
Published: (2025-02-01)

Long-term results of antiviral therapy in patients with chronic hepatitis C with sustained virologic response
by: T. M. Ignatova, et al.
Published: (2013-09-01)

Lack of Tissue Virological Response as a Predictor of Relapse in Chronic Hepatitis D after Completion Bulevirtide Therapy
by: P. O. Bogomolov, et al.
Published: (2024-12-01)

Modern modes of chronic hepatitis B treatment in daily clinical practice
by: M. V. Mayevskaya, et al.
Published: (2014-11-01)

Nucleoside analogues in treatment of liver cirrhosis as an outcome of chronic hepatitis B
by: I. G. Bakulin
Published: (2009-02-01)

Markers of chronic hepatitis B at patients with HIV-infection and treatment approaches
by: S. I. Maksimov, et al.
Published: (2010-11-01)

Virology : an illustrated colour text /
by: Korsman, Stephen N. J.
Published: (2012)

Treatment of chronic hepatitis C by cepeginterferon alpha-2b in combination to ribavirin
by: M. V. Mayevskaya, et al.
Published: (2014-08-01)

Chronic hepatitis B and risk of kidney involvement
by: M. V. Mayevskaya, et al.
Published: (2013-05-01)

Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-03-01)

Long-Term Monitoring of Liver Fibrosis and Steatosis in Patients with Chronic Hepatitis C after Achieving a Sustained Virologic Response to Antiviral Therapy
by: K. R. Dudina, et al.
Published: (2023-02-01)

Impact of hepatic steatosis on the efficacy of antiviral treatment for chronic hepatitis B and the establishment of predictive model: a cohort study
by: Guanghui Ren, et al.
Published: (2025-02-01)

Russian interferon <i>α</i>-2b drug in the treatment of chronic hepatitis C
by: N. B. Kovaleva
Published: (2014-08-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Experience of entecavir in renal graft recipients with chronic hepatitis B
by: M. L. Zubkin, et al.
Published: (2011-09-01)

Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
by: Marina V. Mayevskaya, et al.
Published: (2018-08-01)

Modern modes of chronic hepatitis C treatment
by: V. T. Ivashkin, et al.
Published: (2012-02-01)

Effect of potent nucleos(t)ide analog on alpha fetoprotein changes and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B
by: Qianqian Ma, et al.
Published: (2025-02-01)

Telaprevir in treatment of chronic hepatitis C: safety issues
by: T. M. Ignatova
Published: (2012-07-01)

Application of dicarbamin in treatment of patients by a chronic hepatitis C
by: D. Yu. Konstantinov, et al.
Published: (2011-09-01)

Long-Term Real-World Outcomes of Tenofovir Alafenamide in Chronic Hepatitis B: Detailed Analysis of Treatment-Naive and Experienced Patients
by: Yu-Xuan Song, et al.
Published: (2025-01-01)

Activity of tissue enzymes of the liver and peripheral blood lymphocytes at children with chronic hepatitis B
by: V. G. Bulygin, et al.
Published: (2010-02-01)

The issue of clinical application of non-invasive evaluation of liver fibrosis at chronic hepatitis B
by: Chavdar S. Pavlov, et al.
Published: (2016-08-01)

Lipid spectrum in liver cells and peripheral blood lymphocytes at children with chronic hepatitis B
by: V. G. Bulygin
Published: (2011-05-01)

Role of alpha-fetoprotein in complex diagnostics of progressing course of chronic hepatitis B and C
by: I. A. Belavina, et al.
Published: (2012-06-01)

B-cell non-Hodgkin's lymphoma in the patient with chronic hepatitis C and mixed cryoglobulinemia
by: V. S. Adonyeva, et al.
Published: (2015-03-01)

Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α
by: Kaimin Song, et al.
Published: (2025-02-01)

Corrigendum for “Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort study”
by: Fajuan Rui, et al.
Published: (2025-03-01)

Pegilated interferon α2а in treatment of chronic hepatitis C
by: P. O. Bogomolov, et al.
Published: (2012-09-01)

Clinical Course of Untreated and Treated Chronic Hepatitis B in Pregnant Patients: A Prospective Study
by: Yasemin Nadir, et al.
Published: (2021-12-01)

Role of Interleukin-28B in clearance of HCV in acute and chronic hepatitis patients in Kirkuk city
by: Muhannad Abdullah Alazzawy
Published: (2018-07-01)

Knowledge and awareness of perinatal antiviral use in the prevention of mother-to-child hepatitis B virus transmission among maternal chronic hepatitis carriers
by: Jia Ming Low, et al.
Published: (2024-09-01)

Comparative evaluation of APRI and MELD scores in the prediction of complications of chronic hepatitis in patients infected with hepatitis B or C viruses in Lubumbashi, democratic republic of Congo
by: Arsène Kabamba-Tshikongo, et al.
Published: (2025-02-01)

Hyperferritinemia at the patient with chronic hepatitis C
by: Ye. N. German, et al.
Published: (2009-02-01)

Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients
by: Qiyao Wei, et al.
Published: (2025-02-01)

Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm?
by: S. N. Batskikh
Published: (2014-10-01)

Issues occult hepatitis B virus infection
by: I. A. Morozov, et al.
Published: (2012-07-01)

Resolved Hepatitis B: Achieved or Imaginary Wellbeing?
by: S. N. Batskikh
Published: (2021-04-01)

Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort
by: Hye-Jin Yoo, et al.
Published: (2025-02-01)

Real-Life Experiences with Telaprevir in the Treatment of Chronic Genotype 1 Hepatitis C — The TEPS Study
by: T. Berg, et al.
Published: (2019-01-01)